USL-311 Uses, Dosage, Side Effects and more

USL-311 is under investigation in clinical trial NCT02765165 (Phase 1/2 Study of USL311 Alone and in Combination With Lomustine in Subjects With Advanced Solid Tumors and Relapsed/Recurrent Glioblastoma Multiforme (GBM)).

Trade Name USL-311
Generic USL-311
Type
Formula C24H34N6O
Weight Average: 422.577
Monoisotopic: 422.279409739
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Innovators Monograph

*** Taking medicines without doctor's advice can cause long-term problems.
Share